Aegerion Pharmaceuticals Appoints John Orloff, M.D., as Executive Vice President, Head of R&D
November 03, 2016 16:05 ET
|
Aegerion Pharmaceuticals
CAMBRIDGE, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...